Analyst Ratings for Trevi Therapeutics (TRVI)
TRVI Rating Summary
TRVI Price Target Summary
- Highest: $40.00 (Raymond James)
- Lowest: $20.00 (Morgan Stanley)
- Average: $28.73
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.73 (+72.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$28.73 (+72.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | BMO Capital | Connor Murphy | New Coverage | Outperform (N/A) |
N/A (N/A) |
19.07 (16.66) |
-12.64% | Details |
| 11/13/2025 | Leerink » Updated 4/21/2026 |
Roanna Ruiz | New Coverage | Outperform (N/A) |
25.00 (21.00) |
11.85 (16.66) |
40.59% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
